LK SAMYANG CO., LTD
225190KOSDAQMedical, precision and optical instruments
LK SAMYANG CO., LTD (225190, KOSDAQ) reported KRW 21bn revenue in 2025.
Reported financials
Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.
| Year | Revenue | Operating profit | Net profit | Assets | Equity | Basis |
|---|---|---|---|---|---|---|
| 2021 | 58 | 12 | 11 | 53 | 37 | Consolidated |
| 2022 | 55 | 11 | 8 | 50 | 37 | Consolidated |
| 2023 | 39 | -1 | 1 | 40 | 30 | Consolidated |
| 2024 | 32 | -3 | -1 | 43 | 28 | Consolidated |
| 2025 | 21 | -17 | -19 | 45 | 33 | Consolidated |
Ratios, year by year
Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.
| Year | Operating margin | Net margin | Equity / assets | Return on equity |
|---|---|---|---|---|
| 2021 | 21.2% | 18.4% | 71% | 28.4% |
| 2022 | 20% | 15% | 72.8% | 22.6% |
| 2023 | -2.9% | 1.9% | 76.1% | 2.4% |
| 2024 | -10.1% | -4.5% | 64.2% | -5.2% |
| 2025 | -78.7% | -86.8% | 73.5% | -55.9% |
Revenue moved -62.9% between 2021 and 2025.
Net profit was negative in the 2 most recent consecutive years on file. Counted from the 5 years in which the company filed a net-profit line — a year with no filing is skipped, not read as a loss.
These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.
Market size
| Market capitalisation | KRW 58bn |
|---|---|
| Close price | KRW 821 |
| Listed shares | 70,468,440 |
| Price as of | 20260909 |
Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.
When it was founded
The incorporation date on the company's registration record, as filed with Korea's Financial Supervisory Service. This is when the company was legally formed — not when it first listed, and not when the business it grew out of began trading.
| Incorporated |
|---|
Who runs it
Registered representative directors — in Korea this is the office a CEO holds. Filed with the Financial Supervisory Service (DART). A Korean company can register more than one, and the title beside each name is the rank they carry inside the company.
| Name | Title | Board seat | Years in post |
|---|---|---|---|
| Shin Seung-yeol (신승열) | Representative Director (CEO), Executive Vice President | Inside director | 7 years |
| Kim Hyeong-yeop (김형엽) | Representative Director (CEO), President | Inside director | 1 months |
Roman spellings are ours, converted from the Korean filing. The person may spell their own name differently in English. The Korean name in brackets is what was filed.
Workforce — a side measure, not the main one
| Employees (2025) | 111 |
|---|---|
| Women | 20 (18%) |
| Average tenure | 8.8 years |
| Annual pay, men | KRW 65,000,000 |
| Annual pay, women | KRW 48,000,000 |
| Pay ratio, women to men | 73.8% |
Other companies in Medical, precision and optical instruments
102 listed companies file under this classification. Showing 12.
- MEDIANA Co.,LTD
- LivsMed Inc.
- MEKICS Co., Ltd
- Laseroptek Co., Ltd.
- Micro Digital Co., Ltd.
- LAMEDITECH Co., Ltd.
- Mintech Co., Ltd.
- L&K BIOMED CO., LTD.
- MIRAE CORPORATION
- KOMELON CORPORATION
- MITECH CO.,LTD.
- KNR SYSTEMS Inc.
See the whole Medical, precision and optical instruments list →